Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
11.10
-0.26 (-2.29%)
At close: Sep 4, 2026, 4:00 PM EDT
11.12
+0.02 (0.18%)
After-hours: Sep 4, 2026, 7:32 PM EDT
Alumis Market Cap
Alumis has a market cap or net worth of $1.44 billion as of September 4, 2026. Its market cap has increased by 195.00% in one year.
Market Cap
1.44B
Enterprise Value
970.87M
1-Year Change
195.00%
Ranking
Category
Stock Price
$11.10
ChartMarket Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has increased from $901.92M to $1.44B, an increase of 59.30%. That is a compound annual growth rate of 23.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.44B | 41.01% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 1.50B |
| Ultragenyx Pharmaceutical | 1.50B |
| Vor Biopharma | 1.48B |
| Latigo Biotherapeutics | 1.46B |
| Maze Therapeutics | 1.46B |
| First Tracks Biotherapeutics | 1.45B |
| Cullinan Therapeutics | 1.42B |
| Replimune Group | 1.42B |